Page last updated: 2024-08-26

4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Fatty Liver, Nonalcoholic

4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with Fatty Liver, Nonalcoholic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adhami, N; Benowitz, N; Curras-Collazo, M; Destaillats, H; Dhall, S; Egiebor, I; Frankos, M; Garcia, M; Goodwin, B; Green, HW; Gundel, LA; Havel, C; Hovell, M; Jacob, P; Liles, S; Lyubovitsky, J; Martinez, B; Martins-Green, M; Matt, G; Sleiman, M; Valdez, M; Winickoff, JP; Yu, L1

Other Studies

1 other study(ies) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Fatty Liver, Nonalcoholic

ArticleYear
Cigarette smoke toxins deposited on surfaces: implications for human health.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Animals; Biomarkers; Child, Preschool; Collagen; Fatty Liver; Humans; Infant; Liver; Lung; Maze Learning; Mice; Mice, Inbred C57BL; Nitrosamines; Non-alcoholic Fatty Liver Disease; Psychomotor Agitation; Pulmonary Fibrosis; Pyridines; Skin; Tobacco Smoke Pollution; Wound Healing

2014